The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Recombinant Salmonella vectors in vaccine development.
R Curtiss; S M Kelly; S A Tinge; C O Tacket; M M Levine; J Srinivasan; M Koopman (Profiled Author: Myron M Levine)
Washington University, Department of Biology, St. Louis, MO.
Developments in biological standardization 1994;82():23-33.
A diversity of means are available for the attenuation of Salmonella which can be used to immunize animals and humans orally to elicit mucosal, humoral and cellular immune responses. Avirulent Salmonellae can be genetically engineered to express foreign antigens and the recombinant avirulent Salmonellae are capable of stable, high-level expression of the foreign antigen in the orally immunized animal or human host. The resulting vaccines are safe, efficacious, and are easy and economical to use.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
F R Noriega; G Losonsky; C Lauderbaugh; F M Liao; J Y Wang; M M LevineInfection and immunity 1996;64(8):3055-61.
M M Levine; J Galen; E Barry; F Noriega; S Chatfield; M Sztein; G Dougan; C TacketJournal of biotechnology 1996;44(1-3):193-6.
J E Galen; M M LevineTrends in microbiology 2001;9(8):372-6.
Appears in this Publication
Author of this Publication